Financials

  • Market Capitalization 1.78 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.3
ratio cours/chiffre d'affaires
162.41

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2075
AAPG
Ascentage Pharma Group International - American Depository Shar
19.18 USD-2.24%+2.62%+6.73%-23.28%1.79 B USD
2080
IOVA
Iovance Biotherapeutics, Inc. - Common Stock
3.99 USD-1.24%-5.45%-3.16%+111.11%1.78 B USD
2084
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.34 USD+1.21%-15.01%+1.21%-37.10%1.77 B USD
2112
FTRE
Fortrea Holdings Inc. - Common Stock
18.07 USD+1.18%+4.39%+8.14%+255.01%1.71 B USD